New COVID booster's human trial reveals safe, effective results

New bivalent COVID-19 boosters, targeting both original and BA.5 variants, appear safe and triggers an appropriate immune response in adults.

9 Questions Asked About Updated COVID Boosters

Scientists reveal encouraging findings in first-in-human clinical trial evaluating HIV vaccine approach

Malaria: New vaccine candidate shows efficacy in clinical trials

New COVID booster's human trial reveals safe, effective results

Pfizer Makes Its Case for COVID Booster Shots

New COVID booster's human trial reveals safe, effective results

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Why so few people over 65 gotten new Covid booster shots, despite their risk

Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial